Literature DB >> 2866173

Effect of benzodiazepine hypnotics on all-night sleep EEG spectra.

A A Borbély, P Mattmann, M Loepfe, I Strauch, D Lehmann.   

Abstract

The effect of a single, oral bedtime dose of the benzodiazepine hypnotics flunitrazepam (FR; 2 mg), flurazepam (FR; 30 mg), and triazolam (TR; 0.5 mg) on the sleep stages and the sleep EEG was investigated in eight healthy, young subjects. In comparison to the placebo night, all drugs reduced the percentage of stage 1 and REM sleep, increased stage 2, and decreased the number of stage shifts. For FN and FR, some of these changes persisted in the postdrug night. All-night spectral analysis of the EEG showed a reduction of low-frequency activity (0.25-10.0 Hz) in stages 2, 3 + 4 and REM sleep, changes that persisted for all three drugs in the post-drug night. In the drug nights, activity in the spindle frequency range (11-14 Hz) was enhanced particularly in stage 2 and 3 + 4, activity in the high frequency range (17-25 Hz) particularly in REM sleep and stage 1. In the first third of the drug night, the depression of low-frequency activity in stage 2 was either absent (FR) or less prominent (FN, TR) than in the following part of the night. The results demonstrate that benzodiazepine hypnotics induce specific changes in the EEG spectra which reflect the immediate and residual drug effects more sensitively than conventional sleep scores.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2866173

Source DB:  PubMed          Journal:  Hum Neurobiol        ISSN: 0721-9075


  55 in total

1.  Diazepam-induced changes in sleep: role of the alpha 1 GABA(A) receptor subtype.

Authors:  I Tobler; C Kopp; T Deboer; U Rudolph
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

Review 2.  Drug-induced sleep: theoretical and practical considerations.

Authors:  Jeffrey M Ellenbogen; Edward F Pace-Schott
Journal:  Pflugers Arch       Date:  2011-09-28       Impact factor: 3.657

3.  The effects of eszopiclone on sleep spindles and memory consolidation in schizophrenia: a randomized placebo-controlled trial.

Authors:  Erin J Wamsley; Ann K Shinn; Matthew A Tucker; Kim E Ono; Sophia K McKinley; Alice V Ely; Donald C Goff; Robert Stickgold; Dara S Manoach
Journal:  Sleep       Date:  2013-09-01       Impact factor: 5.849

4.  EEG power spectra response to a 4-h phase advance and gaboxadol treatment in 822 men and women.

Authors:  Junshui Ma; Derk-Jan Dijk; Vladimir Svetnik; Yevgen Tymofyeyev; Shubhankar Ray; James K Walsh; Steve Deacon
Journal:  J Clin Sleep Med       Date:  2011-10-15       Impact factor: 4.062

5.  Can an inert sleeping pill affect sleep? Effects on polysomnographic, behavioral and subjective measures.

Authors:  Fabiana Fratello; Giuseppe Curcio; Michele Ferrara; Cristina Marzano; Alessandro Couyoumdjian; Giovanna Petrillo; Mario Bertini; Luigi De Gennaro
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

Review 6.  Hypnotics and sleep physiology: a consensus report. European Sleep Research Society, Committee on Hypnotics and Sleep Physiology.

Authors:  A A Borbély; T Akerstedt; O Benoit; F Holsboer; I Oswald
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

7.  Effects of olanzapine, risperidone and haloperidol on sleep after a single oral morning dose in healthy volunteers.

Authors:  Sandra Giménez; Susana Clos; Sergio Romero; Eva Grasa; Adelaida Morte; Manuel J Barbanoj
Journal:  Psychopharmacology (Berl)       Date:  2007-01-05       Impact factor: 4.530

Review 8.  Sleep in acute care units.

Authors:  Ahmed BaHammam
Journal:  Sleep Breath       Date:  2006-03       Impact factor: 2.816

9.  Effect of zolpidem on sleep and sleep EEG spectra in healthy young men.

Authors:  D P Brunner; D J Dijk; M Münch; A A Borbély
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

10.  Use of transdermal melatonin delivery to improve sleep maintenance during daytime.

Authors:  D Aeschbach; B J Lockyer; D-J Dijk; S W Lockley; E S Nuwayser; L D Nichols; C A Czeisler
Journal:  Clin Pharmacol Ther       Date:  2009-07-15       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.